A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: A genomewide association study

Hepatology

Volumn 50, Issue 2, 2009, Pages 647-649

  Howell, Jessica A ^a   Visvanathan, Kumar ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIGEN PRESENTATION; DISEASE COURSE; DISEASE PREDISPOSITION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70450177502     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23147     Document Type: Note

References (20)

1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003;362:2089-2094.
2. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73. (Pubitemid 43042691)
3. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007;5:921-931. (Pubitemid 47161142)
4. Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008;135:1192-1199.
5. Laskus T, Radkowski M, Lupa E, Horban A, Cianciara J, Slusarczyk J, et al. Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol 1992;15:174-178.
6. Sheen I, Liaw Y, Lin D, Chu C. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariant analysis in a longitudinal follow up study. J Infect Dis 1994;170:358-361. (Pubitemid 24226364)
7. McMahon BJ. The Natural history of chronic hepatitis B infection. HEPATOLOGY 2009;49(5 Suppl.):S45-S55.
8. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003;98:144-150. (Pubitemid 36135183)
9. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, et al. Tuberculosis and chronic hepatitis B virus infection in africans and variations in the vitamin D receptor gene. J Infect Dis 1999;179:721-724. (Pubitemid 30016163)
10. Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, et al. Association of estrogen receptor α polymorphisms with susceptibility to chronic hepatitis B virus infection. HEPATOLOGY 2004;40:318-326. (Pubitemid 39062849)
11. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC Class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-1069.
12. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007;13:1770-1787. (Pubitemid 46706009)
13. Frodsham AJ. Host genetics and the outcome of hepatitis B viral infection. Transpl Immunol 2005;14:183-186. (Pubitemid 40848524)
14. Frodsham A, Zhang L, Dumpis U, Taib NA, Best S, Durham A, et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A 2006;103:9148-9153. (Pubitemid 43902547)
15. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41:591-595.
16. Fontenot A, Torres M, Marshall W, Newman L, Kotzin B. Beryllium presentation to CD4- T cells underlies disease susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A 2000;97:12717-12722. (Pubitemid 30840482)
17. Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y, et al. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006;45:805-812. (Pubitemid 44646684)
18. Yang H-I, Lu S-N, Liaw Y-F, You S-L, Sun C-A, Wang L-Y, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168-174. (Pubitemid 34764820)
19. Tang B, Kruger W, Chen GH, Shen F-M, Lin W, Mboup S, et al. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol 2004;72:35-40. (Pubitemid 37484740)
20. Chen C-J, Yang H-I, Su J, Jen C-L, You S-L, Lu S-N, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73. (Pubitemid 43042691)